The scar treatment market has seen significant growth in recent years, driven by various factors such as the increasing prevalence of skin disorders and injuries, rising demand for aesthetic procedures, and advancements in scar treatment technologies. Scars are a common outcome of wounds, surgeries, burns, acne, and other skin conditions, and the market offers a range of products and therapies to minimize their appearance and improve skin texture.
Worldwide revenue from the scar treatment market stands at US$ 11.2 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 3.0% to reach a valuation of US$ 15.6 Bn by the end of 2033.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/10819
With growing incidences of chronic illnesses coupled with rising healthcare costs, there is a need for future health systems that would deliver more scalable, accessible, and equitable solutions, that too, while safeguarding the environment. As such, AI-based automation is the buzzword. Image-guided therapy can’t be imagined these days without the intervention of AI. Also, auto-logging various steps of minimally invasive procedures is on the anvil. Virtual collaborations are also seen amongst providers, thereby offering various poignant opportunities. This would be the scenario with healthcare electronics market in the near future.
In the report, the global scar treatment market is analyzed based on product type, scar type, end-user (distribution channel), and region. Based on product type, the overall market has been segmented into topical products, laser products, surface treatment products, and injectable products. The topical product segment is further segmented into creams, gels, oils, and silicone gel sheets. The laser segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Based on scar type, the market has been sub-segmented into atrophic scars, hypertrophic scars and keloids, contractures, and stretch marks.
The distribution channels or end-users in the market include hospitals, private clinics, pharmacies and retail drug stores, and e-commerce. The market has been analyzed in terms of value. In the overall market, topical products and atrophic scars are the prime segments driving revenue growth currently. Accordingly, the topical product type segment is expected to reach a value of 7,318.7 Mn by the end of 2024, registering a moderate CAGR over the forecast period.
The prime drivers for the market include the availability of attractive reimbursement facilities in developed markets and rising incidences of atrophic scars (primarily acne) in developing markets, primarily due to rapidly changing food habits and lifestyles. Furthermore, growing adoption of combination therapeutics is another factor expected to drive demand for various combinations of scar treatment product and treatments over the forecast period.
Company Profiles:
- Smith & Nephew PLC
- Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
- GC Aesthetics plc
- Sientra, Inc.,
- Groupe Sebbin SAS
- Polytech Health & Aesthetics GmbH
- Establishment Labs S.A.
- HansBiomed Co., Ltd
- CEREPLAS
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/10819
Currently, there are no formalized guidelines for treatment of scars. All treatments are done on a best-effort basis, guided mostly through word-of-mouth by expert clinicians and surgeons. However, efforts are underway to formalize treatment guidelines at least for common scars. In this regard, under the U.K. government’s cosmetic intervention guidelines, patient and patient parties need access to independent and evidence-based information to form their decisions. Many of these scar treatment and aesthetic beautification procedures are considered similar to ‘consumer goods’ by both the purchaser and provider. A change in this perspective could help boost manufacturers and service provider’s potential revenue base.
Barriers to the market include fragmented documented clinical evidence for popular topical products such as onion extract gels (containing silicone). This hampers the product uptake by the educated section of the patient base in both developed and developing countries. Other barriers include psychological issues such as fear of side-effects and consideration of scar treatment as a non-necessary expenditure item in the overall consumption basket. Even some of the well-known regulatory agencies do not accept scar treatments as medically necessary as they mostly aren’t life-changing in nature.
Based on region, the market has been divided into North America, Latin America, Europe, Asia-Pacific, and the MEA. Developed pharmaceutical markets such as the U.S. and EU are expected to emerge as the main markets for scar treatment products over the forecast period while markets in Brazil and Central Asia are expected to witness growing adoption of laser treatments due to booming medical tourism and aesthetic corrective procedures in these regions.
Increasing involvement of patients in treatment formulation processes is an important attribute being adopted by reputed physicians as it could lead to a marked improvement in adherence levels of prescribed treatments and increase treatment effectiveness.
This report assesses the market trends, by product, scar type, end-user and region, to offer analytical insights about the potential emerging demand for particular scar treatments in specific regions. North America is estimated to dominate the scar treatment market over the forecast period, accounting for a maximum revenue share of the overall market by the end of 2015. By 2024 end, North America and Europe markets are expected to account for over three-fifth market value share of the global scar treatment market. Markets in Latin America and APAC region are estimated to expand at the most moderate CAGR over the forecast period.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/10819
The global scar treatment market is segmented as follows:
By Product Type
- Topical Products
- Creams
- Gels
- Oils
- Silicone gel sheets
- Laser Products
- CO2 laser
- Excimer laser
- Pulse-dyed laser
- Surface Treatment Products
- Injectable Products
By Scar Type
- Atrophic Scars
- Acne
- Ice Pick acne
- Boxcar acne
- Rolling acne
- Trauma and Injuries
- Acne
- Hypertrophic Scars and Keloids
- Contractures
- Stretch Marks
By End User/Distribution Channel
- Hospitals
- Private Clinics
- Pharmacies and Retail Drug Stores
- E-commerce
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
US Office: 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call – 1-888-863-3700
Sales – sales@persistencemarketresearch.com
